USAID and PEPFAR announce that they have secured a 30% price reduction on the TB preventive treatment regimen called 3HP, taking the price from $14.25 to $9.99 for a three-month patient course.

Global Fund, Stop TB Partnership and USAID announce new collaboration with Danaher to reduce price and increase access to Cepheid’s TB test. Five million additional tests can be procured with this lower price.

GENEVA/WASHINGTON, 09 March 2023 – The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), the United States Agency for International Development (USAID) and the Stop TB Partnership announced a new collaboration today with Molbio Diagnostics that significantly reduces the price of the Truenat® MTB and MTB Plus tests, including a supply of MTB-RIF Dx tests for subsequent testing for rifampicin resistance, and ensures timely service and maintenance of diagnostic instruments. This collaboration will expand equitable access to quality rapid testing to underserved populations across all countries supported by the Global Fund, USAID and the Stop TB Partnership.

The U.S. Agency for International Development (USAID) announced $57 million will be dedicated to urgently needed tuberculosis (TB) recovery efforts in seven high burden countries: Bangladesh, India, Indonesia, the Philippines, South Africa, Tajikistan, and Ukraine. Alongside COVID-19, TB is the leading infectious disease killer, particularly in low- and middle-income countries, sickening ten million people and taking 1.4 million lives every year. To address the COVID-19 pandemic’s devastating impact on TB services, this assistance will strengthen simultaneous testing for both TB and COVID-19, improve TB diagnosis services, and identify TB cases through contact investigations and community screenings. This commitment represents approximately 19 percent of USAID’s annual TB funding.

The Stop TB Partnership and USAID launch a new report assessing the governance of National TB Programmes in 22 countries which together account for over 70% of the global TB burden.

The USAID TB CARE II Project will host a webinar on reducing TB transmission among health care workers on 19 November 2019.

The U.S. Agency for International Development (USAID) is pleased to announce a five-year, $300 million award, the TB Implementation Framework Agreement (TIFA), to improve the prevention, detection, and treatment of tuberculosis (TB). The lead partner in the cooperative agreement for the TIFA effort is John Snow, Inc., Research and Training Institute.

The one-day symposium will be convened on 20 July 2019 in Mexico City, Mexico just prior to the 10th IAS Conference on HIV Science (IAS 2019), and will be co-hosted by the International AIDS Society (IAS) in collaboration with the Stop TB Partnership and the United States Agency for International Development (USAID).

USAID launched a new website providing a platform to help inform global efforts to maximize investments and move toward eliminating TB. It allows users to explore, analyze, and download key TB data from USAID TB priority countries. Country data dashboards, program objectives, and progress indicators help inform programs for better decision-making.

The U.S. Agency for International Development (USAID) announced a new TB funding opportunity, TB Local Organizations Network Project (LON).